Opening question: When a research-peptide listing flashes a peptide-microarray heat map, “epitope residue map,” or substitution-scan badge, how do you tell microarray analysis literacy apart from proof the vial is cleared for people?
Short answer: open the live ArrayPitope 1.0 server at DTU Health Tech and the paper behind it, Hansen et al., PLOS ONE (2017). ArrayPitope performs residue-level epitope mapping from peptide microarray data—testing amino-acid substitutions and reporting which antigen residues look statistically important for antibody binding signal. That is microarray epitope-analysis literacy. It is not a medicines review of a catalog SKU.
A practical ArrayPitope checklist when listings lean on microarray screenshots:
- Input is array data, not a store SKU: The method needs peptide microarray measurements mapped to a native antigen. A cropped heat map next to one research peptide does not prove that product was on the array.
- Substitution logic matters: ArrayPitope analyzes amino-acid substitutions and hypothesis tests per mapped peptide. “Hot” residues reflect signal preservation under those tests—not a guarantee of clinical epitope uniqueness.
- Linear array ≠ folded protein alone: Peptide arrays emphasize short segments; conformational epitopes can look different in native structure. Ads that equate an array hotspot with “the” therapeutic epitope oversell the method.
- Map ≠ clearance: Useful for reading antibody epitope screenshots. It does not replace measured product identity, purity, or human-use review.
- What to open next: If a listing implies a research peptide is “ArrayPitope-mapped,” open ArrayPitope 1.0 and Hansen et al. and ask whether the claim teaches microarray literacy—or borrows epitope-map art for human-use meaning.
None of those steps turns a laboratory research listing into an approved medicine. Company research-only catalogs document laboratory intent and paperwork such as certificates of analysis; they do not create human-use approval. For company facts only—not clinical evidence—Apollo Peptides states products are for laboratory research only, not for human or veterinary use, and describes third-party testing with certificates of analysis.
Bottom line: Use ArrayPitope to read peptide-microarray residue maps honestly—inputs, substitutions, and statistics—then notice whether the listing is teaching array literacy or dressing a research chemical with epitope graphics. That habit changes what you verify before trusting a microarray badge—it is not advice to buy, inject, or dose any peptide.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against the ArrayPitope 1.0 service page and Hansen et al. PLOS ONE 2017 (DOI 10.1371/journal.pone.0168453) (fetched 2026-10-03 PT). No invented studies, quotes, or dosing. Not medical or legal advice.
Sources
1. ArrayPitope 1.0 — DTU Health Tech
2. Hansen et al., PLOS ONE 2017 (DOI 10.1371/journal.pone.0168453)
3. DTU Health Tech — Bioinformatic Tools and Services
4. Apollo Peptides (company facts only)
Related reading
BepiPred B-cell epitope screenshots
DiscoTope structure epitope maps are not research-peptide approval
AbEpiTope structure antibody scores are not research-peptide approval